The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

A new executive order aims to speed up reviews of certain psychedelic drugs, as the Trump administration argues that new tools are needed to address the mental health crisis.

People who view their depression or anxiety as the result of a chemical imbalance tend to use antidepressants for much longer ...

President Trump has signed an executive order to fast-track psychedelic research and FDA approval, sparking debate among ...

President Trump signed an executive order on Saturday to make some psychedelic drugs more available to treat mental health ...

US President Donald Trump on Saturday announced reforms to speed up access to medical research and treatment based on ...

President Donald Trump was surprised to read on Saturday, during the announcement of an executive order fast-tracking ...

President Trump signs a monumental executive order fast-tracking psychedelics for mental health treatment, and ibogaine is repeatedly highlighted. What is ibogaine?

The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier ...

For centuries, healers knew what science is only now confirming: psilocybin is a powerful healing medicine. Could magic ...

The executive order signed by President Donald Trump aims to accelerate research into psychedelic drugs to help veterans.